Opportunistic Infections Citation List:
December 22 - January 6, 2011
ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
1. Synthesis and Antimicrobial Activity of Some New N-Substituted Quinoline Derivatives of 1H-Pyrazole. Thumar, N.J. and M.P. Patel. Archiv Der Pharmazie, 2010. [Epub ahead of print]; PMID[21181734].
[Pubmed]. OI_1221-010511.
2. Benzothieno[3,2-b]quinolinium and 3-(phenylthio)quinolinium compounds: Synthesis and evaluation against opportunistic fungal pathogens.Boateng, C.A., S.V. Eyunni, X.Y. Zhu, J.R. Etukala, B.A. Bricker, M.K. Ashfaq, M.R. Jacob, S.I. Khan, L.A. Walker, and S.Y. Ablordeppey. Bioorganic & Medicinal Chemistry, 2011. 19(1): p. 458-70; PMID[21134759].
[Pubmed]. OI_1221-010511.
3. 3-[Benzimidazo- and 3-[benzothiadiazoleimidazo-(1,2-c)quinazolin-5-yl]-2H-chromene-2-ones as potent antimicrobial agents.Kuarm, B.S., Y.T. Reddy, J.V. Madhav, P.A. Crooks, and B. Rajitha. Bioorganic and Medicinal Chemistry Letters, 2011. 21(1): p. 524-7; PMID[21134751].
[Pubmed]. OI_1221-010511.
4. Microwave assisted one pot synthesis of some novel 2,5-disubstituted 1,3,4-oxadiazoles as antifungal agents. Sangshetti, J.N., A.R. Chabukswar, and D.B. Shinde. Bioorganic and Medicinal Chemistry Letters, 2011. 21(1): p. 444-8; PMID[21095127].
[Pubmed]. OI_1221-010511.
5. Penetratin analogues acting as antifungal agents. Garibotto, F.M., A.D. Garro, A.M. Rodriguez, M. Raimondi, S.A. Zacchino, A. Perczel, C. Somlai, B. Penke, and R.D. Enriz. European Journal of Medicinal Chemistry, 2011. 46(1): p. 370-7; PMID[21093119].
[Pubmed]. OI_1221-010511.
6. Synthesis and biological evaluation of novel 2,4-disubstituted-1,3-thiazoles as anti-Candida spp. agents. Chimenti, F., B. Bizzarri, A. Bolasco, D. Secci, P. Chimenti, A. Granese, S. Carradori, M. D'Ascenzio, D. Lilli, and D. Rivanera. European Journal of Medicinal Chemistry, 2011. 46(1): p. 378-82; PMID[21084135].
[Pubmed]. OI_1221-010511.
7. Antifungal activity of lawsone methyl ether in comparison with chlorhexidine.Sritrairat, N., N. Nukul, P. Inthasame, A. Sansuk, J. Prasirt, T. Leewatthanakorn, U. Piamsawad, A. Dejrudee, P. Panichayupakaranant, K. Pangsomboon, N. Chanowanna, J. Hintao, R. Teanpaisan, W. Chaethong, P. Yongstar, N. Pruphetkaew, V. Chongsuvivatwong, and W. Nittayananta. Journal of Oral Pathology and Medicine, 2011. 40(1): p. 90-96; PMID[20738748].
[Pubmed]. OI_1221-010511.
8. Resveratrol and its antifungal activity against Candida species. Weber, K., B. Schulz, and M. Ruhnke. Mycoses, 2011. 54(1): p. 30-3; PMID[19703269].
[Pubmed]. OI_1221-010511.
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
9. Susceptibility of clinical Mycobacterium tuberculosis isolates to a potentially less toxic derivate of linezolid; PNU-100480. Alffenaar, J.W., T. van der Laan, S. Simons, T.S. van der Werf, P.J. van de Kasteele, H. de Neeling, and D. van Soolingen. Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[21199931].
[Pubmed]. OI_1221-010511.
10. Chemical modification of capuramycins to enhance antibacterial activity.Bogatcheva, E., T. Dubuisson, M. Protopopova, L. Einck, C.A. Nacy, and V.M. Reddy. The Journal of Antimicrobial Chemotherapy, 2010. [Epub ahead of print]; PMID[21186194].
[Pubmed]. OI_1221-010511.
11. Synthesis and anti-mycobacterial activities of triazoloquinolones. Carta, A., M. Palomba, I. Briguglio, P. Corona, S. Piras, D. Jabes, P. Guglierame, P. Molicotti, and S. Zanetti European Journal of Medicinal Chemistry, 2011. 46(1): p. 320-6; PMID[21145625].
[Pubmed]. OI_1221-010511.
12. Synthesis and in vitro antimycobacterial activity of 8-OCH(3) ciprofloxacin methylene and ethylene isatin derivatives. Feng, L.S., M.L. Liu, S. Zhang, Y. Chai, B. Wang, Y.B. Zhang, K. Lv, Y. Guan, H.Y. Guo, and C.L. Xiao. European Journal of Medicinal Chemistry, 2011. 46(1): p. 341-8; PMID[21146257].
[Pubmed]. OI_1221-010511.
13. Synthetic UDP-furanoses as potent inhibitors of mycobacterial galactan biogenesis.Peltier, P., M. Belanova, P. Dianiskova, R. Zhou, R.B. Zheng, J.A. Pearcey, M. Joe, P.J. Brennan, C. Nugier-Chauvin, V. Ferrieres, T.L. Lowary, R. Daniellou, and K. Mikusova. Chemistry and Biology. Journal of Chemical Information and Modeling, 2010. 17(12): p. 1356-66; PMID[21168771].
[Pubmed]. OI_1221-010511.
14. Synthesis of sugar-amino acid-nucleosides as potential glycosyltransferase inhibitors.Vembaiyan, K., J.A. Pearcey, M. Bhasin, T.L. Lowary, and W. Zou. Bioorganic & Medicinal Chemistry, 2011. 19(1): p. 58-66; PMID[21167722].
[Pubmed]. OI_1221-010511.
15. Design, synthesis and antimycobacterial activities of 1-methyl-2-alkenyl-4(1H)-quinolones.Wube, A.A., A. Hufner, C. Thomaschitz, M. Blunder, M. Kollroser, R. Bauer, and F. Bucar. Bioorganic & Medicinal Chemistry, 2011. 19(1): p. 567-79; PMID[21106378].
[Pubmed]. OI_1221-010511.
Citations from the ISI Web of Knowledge Listings for O.I.
16. Synthesis and biological evaluation of substituted alpha- and beta-2,3-dihydrofuran naphthoquinones as potent anticandidal agents. Freire, C.P.V., S.B. Ferreira, N.S.M. de Oliveira, A.B.J. Matsuura, I.L. Gama, F.D. da Silva, M. de Souza, E.S. Lima, and V.F. Ferreira. Medchemcomm, 2010. 1(3): p. 229-232; ISI[000284980000007].
[WOS]. OI_1221-010511.